Talazoparib (Talzenna™) is a PARP inhibitor used in the treatment of some types of breast cancer.
What's New
Cemiplimab-rwlc (Libtayo®) is a monoclonal antibody used in the treatment of some cases of squamous cell cancer of the skin.
Dacomitinib is a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancers with certain EGFR mutations.
Duvelisib (Copiktra ™) is a kinase inhibitor used in the treatment of some cases of CLL, small lymphocytic lymphoma and follicular lymphoma.
OncoLink Apps
Blogs
OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Medicare Part D-What You Need to Know for Open Enrollment
by Christina Bach, MSW, LCSW, OSW-COct 18, 2018
Medicare Open Enrollment is Almost Here-What You Need to Know
by Christina Bach, MSW, LCSW, OSW-COct 12, 2018
Cancer Awareness
Breast Cancer Awareness Month
October is breast cancer awareness month- in case you haven't yet noticed the sea of pink. We would like to not only support those fighting and surviving breast cancer, but we would like to encourage others to learn more about risk and prevention. Risk is complicated, but incorporating a healthy diet, exercise and maintaining a healthy weight, can reduce your risk of developing breast cancer OR having a recurrence. You can also learn more about cancer screening for women in general.
Need Cancer Patient Education Tools?
Our award winning cancer education content is now available for licensing and syndication.
I Wish U Knew!
I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.